Peanut OIT Anaphylaxis Risk Higher Than Placebo, Avoidance

Peanut oral immunotherapy (OIT) in clinical trials involving children was associated with substantially greater risk for anaphylaxis and other allergic reactions, compared to placebo or peanut avoidance, a systematic review found.

Source: Peanut OIT Anaphylaxis Risk Higher Than Placebo, Avoidance

About the Author

Stephanie Figon, MS, RDN, LD

Founder of NutriScape.NET. As a dietitian since 1992, Steph Figon has had experiences in consulting, 15 years in clinical, and has operated a private practice nutrition counseling office for since 2011. Connect on Linkedin